Build and execute a sample analysis strategy that ensures speed without compromising quality

Since clinical trials are critical to determining the safety and efficacy of a new drug, it is vital to find a bioanalytical partner that will manage your program with speed and integrity. Aliri can ensure that the methods developed translate into a robust sample analysis strategy that will enable scale, speed, and integrity throughout the lifecycle of your drug program. We have the expertise to have your methods developed and validated in a timely manner for pre-clinical studies or clinical studies.

Our dedicated scientists, technical experts, and program managers will help you:

  • Gain access to on-time, compliant data and analytical results
  • Ensure proper handling and QC/QA
  • Provide a validated method following the latest guidance
  • Build in flexibility to accommodate modifications as needed
  • Accommodate small and large sample analysis projects
  • Ensure high throughput and scalability

Due to our vast experience with both small and large molecules, our team understands the unique challenges and differences in terms of sensitivity, timelines, etc. We have a vast assortment of mass spectrometry instrumentation to accommodate small and large molecule projects.

Our bioanalytical experience and expertise in applying LC-MS/MS and LC-HRMS (high-resolution mass spectrometry) include:

null

Vast biologic diversity spanning from small (1 kDA) therapeutic peptides to large (900 kDA IgM) molecules such as:

-

  • Traditional
  • Endogenous
  • Chiral compounds
  • Oligonucleotides
null

Development and validation of mass spectrometry assays

-

Using surrogate peptides produced by proteolytic digestion of proteins for quantification
null

Semi-quantitative analysis of intact proteins

-

  • Traditional
  • Endogenous
  • Chiral compounds
  • Oligonucleotides
5+

Samples Analyzed

150

Types of Biospecimens

16

FDA Audits

Is your molecule ready for sample analysis?